🔴 GRAIL is trading 4.7% down today amid a broader biotech selloff and reversal of yesterday's rally

GRAIL is trading 4.7% down at $67.77 today, reversing a portion of yesterday's gains as the broader biotech sector faces selling pressure.

• The decline follows a sharp 12.1% rebound in the previous session, which was driven by a tech-led rally on cooling inflation data and strong Microsoft earnings.
• There are no fresh company-specific headlines or analyst calls; the move appears tied to a weak biotech tape, with the XBI ETF down over 3% amid sector-wide risk-off sentiment.